v3 Template
C

Capricor Therapeutics

Biotechnology SAN DIEGO ~560 employees
Founded
--
Employees (Est.)
~560
28 leaders known
Total Funding
$334.3M
Funding Rounds
4
Last Funding
2025-12-05

About Capricor Therapeutics

Capricor Therapeutics is a biotechnology company focused on developing transformative cell and exosome-based therapeutics, with a primary emphasis on drug development for Duchenne muscular dystrophy and other serious diseases. They prioritize patient-focused medicine while advancing precision science.

Products & Services

Deramiocel (Biologic Medicine):A biologic medicine under development for treating Duchenne muscular dystrophy.
Exosomes Technology:A novel therapeutic approach using exosome science to address a broad range of serious diseases.
Allogeneic Cardiosphere-Derived Cells (CDCs):Cell-based therapy explored for multiple therapeutic applications.

Specialties

Cell-based therapeutics Exosome-based therapeutics Precision medicine Duchenne Muscular Dystrophy treatment

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Public Offering
T: -
FT: Public Offering
A: 150000000
MR: -
FA: $150 million
FAN: 150000000
D: 2025-12-05
FD: 2025-12-05
3 investors
2 RT: Public Offering
T: -
FT: Public Offering
A: 86300000
MR: -
FA: approximately $86.3 million
FAN: 86300000
D: 2024-10-18
FD: 2024-10-18
2 investors
3 RT: Public Offering
T: -
FT: Public Offering
A: 75000000
MR: -
FA: approximately $75 million
FAN: 75000000
D: 2024-10-17
FD: 2024-10-17
2 investors
4 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering
A: 23000000
MR: -
FA: approximately $23 million
FAN: 23000000
D: 2023-09-29
FD: 2023-09-29
2 investors
Public Offering Latest
2025-12-05
$150.0M
3 investors (Pro only)
Public Offering 2024-10-18
$86.3M
Public Offering 2024-10-17
$75.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

C

Craig McDonald

M.D.

P

Pat Furlong

Scientific Advisor

M

Michelle Eagle

Scientific Advisor

T

Timothy Franson

M.D., FACP, FIDSA

M

Michael Taylor

M.D., Ph.D.

S

Suzanne Hendrix

Ph.D.

View 25 more team members with Pro

Unlock Full Team Directory

Recent News

Capricor Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~560 employees (est.)
Locations
SAN DIEGO
San Diego

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro